Collaboration to Reduce Disparities in Hypertension
1 other identifier
interventional
802
1 country
3
Brief Summary
A large number of African-American and low socioeconomic patients have poorly controlled high blood pressure because of not being able to take their high blood pressure medications. This puts these patients at higher risk of heart and kidney disease, stroke and death. This study is designed to reduce the barriers that prevent patients from taking their high blood pressure medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4 hypertension
Started Mar 2005
Typical duration for phase_4 hypertension
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2005
CompletedFirst Submitted
Initial submission to the registry
August 19, 2005
CompletedFirst Posted
Study publicly available on registry
August 22, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2008
CompletedMay 12, 2016
May 1, 2016
3.4 years
August 19, 2005
May 10, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood pressure
6 months
Secondary Outcomes (2)
Cost
12 months
Blood pressure
12 months
Study Arms (4)
1
OTHERControl
2
EXPERIMENTALReduction of financial barrier
3
EXPERIMENTALComputer Intervention
4
EXPERIMENTALReduction of financial barrier and Computer Intervention
Interventions
Eligibility Criteria
You may qualify if:
- Patients of the Philadelphia Veterans Administration Hospital Primary Care Clinic, PinnacleHealth Adult Outpatient Clinics and the VA Pittsburgh Healthcare System who have a diagnosis of hypertension; are currently taking antihypertensive medications; and have elevated blood pressure.
You may not qualify if:
- Under 21 years of age
- Have a diagnosis of:
- Atrial fibrillation;
- Metastatic cancer;
- End stage renal disease (ESRD) with dialysis;
- Dementia;
- New York Heart Association (NYHA) class IV congestive heart failure (CHF);
- Blind or deaf;
- Other reason for life expectancy of less than 1 year.
- Are currently participating in another experimental study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- Pennsylvania Department of Healthcollaborator
- Dickinson Collegecollaborator
- Pfizercollaborator
Study Sites (3)
PinnacleHealth Adult Outpatient Clinics
Harrisburg, Pennsylvania, 17101, United States
Veterans Administration Medical Center
Philadelphia, Pennsylvania, 19104, United States
VA Pittsburgh Healthcare System
Pittsburgh, Pennsylvania, 15240, United States
Related Publications (1)
Volpp KG, Troxel AB, Long JA, Ibrahim SA, Appleby D, Smith JO, Jaskowiak J, Helweg-Larsen M, Doshi JA, Kimmel SE. A randomized controlled trial of co-payment elimination: the CHORD trial. Am J Manag Care. 2015 Aug;21(8):e455-64.
PMID: 26625505DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephen E. Kimmel, MD, MSCE
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Stephen E. Kimmel, M.D., M.S.C.E,
Study Record Dates
First Submitted
August 19, 2005
First Posted
August 22, 2005
Study Start
March 1, 2005
Primary Completion
August 1, 2008
Study Completion
August 1, 2008
Last Updated
May 12, 2016
Record last verified: 2016-05